The European directive on basic safety standards (Council directive 2013/59 Euratom) mandates dosimetry-based treatment planning for radiopharmaceutical therapies. The directive comes into operation February 2018, and the aim of a report produced by the Internal Dosimetry Task Force of the European Association of Nuclear Medicine is to address this aspect of the directive. A summary of the report is presented.
Dosimetry-based treatment planning for molecular radiotherapy. A summary of the 2017 report from the Internal dosimetry task force / Stokke, C., Gabiña, P.M., Solný, P., Cicone, F., Sandström, M., Gleisner, K.S., Chiesa, C., Spezi, E., Paphiti, M., Konijnenberg, M., Aldridge, M., Tipping, J., Wissmeyer, M., Brans, B., Bacher, K., Kobe, C., Flux, G.. - In: EJNMMI PHYSICS. - ISSN 2197-7364. - 4:1(2017), p. 27. [10.1186/s40658-017-0194-3]
Dosimetry-based treatment planning for molecular radiotherapy. A summary of the 2017 report from the Internal dosimetry task force
Cicone, Francesco;
2017
Abstract
The European directive on basic safety standards (Council directive 2013/59 Euratom) mandates dosimetry-based treatment planning for radiopharmaceutical therapies. The directive comes into operation February 2018, and the aim of a report produced by the Internal Dosimetry Task Force of the European Association of Nuclear Medicine is to address this aspect of the directive. A summary of the report is presented.| File | Dimensione | Formato | |
|---|---|---|---|
|
Stokke_Molecular-radiotherapy_2017.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
481.12 kB
Formato
Adobe PDF
|
481.12 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
